Cargando…
Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice
AIMS: In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a conditional zone between 200 and 250 bpm and a shock zone for arrhythmias >250 bpm. The extent to which this programming approach...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227499/ https://www.ncbi.nlm.nih.gov/pubmed/36932709 http://dx.doi.org/10.1093/europace/euac234 |
_version_ | 1785050786136326144 |
---|---|
author | Rordorf, Roberto Viani, Stefano Biffi, Mauro Pieragnoli, Paolo Migliore, Federico D’Onofrio, Antonio Nigro, Gerardo Francia, Pietro Ferrari, Paola Dello Russo, Antonio Bisignani, Antonio Ottaviano, Luca Palmisano, Pietro Caravati, Fabrizio Pisanò, Ennio Pani, Antonio Botto, Giovanni Luca Lovecchio, Mariolina Valsecchi, Sergio Vicentini, Alessandro |
author_facet | Rordorf, Roberto Viani, Stefano Biffi, Mauro Pieragnoli, Paolo Migliore, Federico D’Onofrio, Antonio Nigro, Gerardo Francia, Pietro Ferrari, Paola Dello Russo, Antonio Bisignani, Antonio Ottaviano, Luca Palmisano, Pietro Caravati, Fabrizio Pisanò, Ennio Pani, Antonio Botto, Giovanni Luca Lovecchio, Mariolina Valsecchi, Sergio Vicentini, Alessandro |
author_sort | Rordorf, Roberto |
collection | PubMed |
description | AIMS: In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a conditional zone between 200 and 250 bpm and a shock zone for arrhythmias >250 bpm. The extent to which this programming approach is adopted in clinical practice is still unknown, as is its impact on the rates of inappropriate and appropriate therapies. METHODS AND RESULTS: We assessed ICD programming on implantation and during follow-up in a cohort of 1468 consecutive S-ICD recipients in 56 Italian centres. We also measured the occurrence of inappropriate and appropriate shocks during follow-up. On implantation, the median programmed conditional zone cut-off was set to 200 bpm (IQR: 200–220) and the shock zone cut-off was 230 bpm (IQR: 210–250). During follow-up, the conditional zone cut-off rate was not significantly changed, while the shock zone cut-off was changed in 622 (42%) patients and the median value increased to 250 bpm (IQR: 230–250) (P < 0.001). UNTOUCHED-like programming of detection cut-offs was adopted in 426 (29%) patients immediately after device implantation, and in 714 (49%, P < 0.001) at the last follow-up. UNTOUCHED-like programming was independently associated with fewer inappropriate shocks (hazard ratio 0.50, 95%CI 0.25–0.98, P = 0.044), and had no impact on appropriate and ineffective shocks. CONCLUSIONS: In recent years, S-ICD implanting centres have increasingly programmed high arrhythmia detection cut-off rates, at the time of implantation in the case of new S-ICD recipients, and during follow-up in the case of pre-existing implants. This has contributed significantly to reducing the incidence of inappropriate shocks in clinical practice. Rordorf: Programming of the S-ICD CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/Identifier: NCT02275637 |
format | Online Article Text |
id | pubmed-10227499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102274992023-05-31 Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice Rordorf, Roberto Viani, Stefano Biffi, Mauro Pieragnoli, Paolo Migliore, Federico D’Onofrio, Antonio Nigro, Gerardo Francia, Pietro Ferrari, Paola Dello Russo, Antonio Bisignani, Antonio Ottaviano, Luca Palmisano, Pietro Caravati, Fabrizio Pisanò, Ennio Pani, Antonio Botto, Giovanni Luca Lovecchio, Mariolina Valsecchi, Sergio Vicentini, Alessandro Europace Clinical Research AIMS: In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a conditional zone between 200 and 250 bpm and a shock zone for arrhythmias >250 bpm. The extent to which this programming approach is adopted in clinical practice is still unknown, as is its impact on the rates of inappropriate and appropriate therapies. METHODS AND RESULTS: We assessed ICD programming on implantation and during follow-up in a cohort of 1468 consecutive S-ICD recipients in 56 Italian centres. We also measured the occurrence of inappropriate and appropriate shocks during follow-up. On implantation, the median programmed conditional zone cut-off was set to 200 bpm (IQR: 200–220) and the shock zone cut-off was 230 bpm (IQR: 210–250). During follow-up, the conditional zone cut-off rate was not significantly changed, while the shock zone cut-off was changed in 622 (42%) patients and the median value increased to 250 bpm (IQR: 230–250) (P < 0.001). UNTOUCHED-like programming of detection cut-offs was adopted in 426 (29%) patients immediately after device implantation, and in 714 (49%, P < 0.001) at the last follow-up. UNTOUCHED-like programming was independently associated with fewer inappropriate shocks (hazard ratio 0.50, 95%CI 0.25–0.98, P = 0.044), and had no impact on appropriate and ineffective shocks. CONCLUSIONS: In recent years, S-ICD implanting centres have increasingly programmed high arrhythmia detection cut-off rates, at the time of implantation in the case of new S-ICD recipients, and during follow-up in the case of pre-existing implants. This has contributed significantly to reducing the incidence of inappropriate shocks in clinical practice. Rordorf: Programming of the S-ICD CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/Identifier: NCT02275637 Oxford University Press 2023-03-18 /pmc/articles/PMC10227499/ /pubmed/36932709 http://dx.doi.org/10.1093/europace/euac234 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Rordorf, Roberto Viani, Stefano Biffi, Mauro Pieragnoli, Paolo Migliore, Federico D’Onofrio, Antonio Nigro, Gerardo Francia, Pietro Ferrari, Paola Dello Russo, Antonio Bisignani, Antonio Ottaviano, Luca Palmisano, Pietro Caravati, Fabrizio Pisanò, Ennio Pani, Antonio Botto, Giovanni Luca Lovecchio, Mariolina Valsecchi, Sergio Vicentini, Alessandro Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title | Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title_full | Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title_fullStr | Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title_full_unstemmed | Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title_short | Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
title_sort | reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227499/ https://www.ncbi.nlm.nih.gov/pubmed/36932709 http://dx.doi.org/10.1093/europace/euac234 |
work_keys_str_mv | AT rordorfroberto reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT vianistefano reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT biffimauro reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT pieragnolipaolo reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT migliorefederico reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT donofrioantonio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT nigrogerardo reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT franciapietro reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT ferraripaola reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT dellorussoantonio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT bisignaniantonio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT ottavianoluca reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT palmisanopietro reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT caravatifabrizio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT pisanoennio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT paniantonio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT bottogiovanniluca reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT lovecchiomariolina reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT valsecchisergio reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice AT vicentinialessandro reductionininappropriatetherapiesthroughdeviceprogramminginsubcutaneousimplantabledefibrillatorpatientsdatafromclinicalpractice |